$15.83
0.624.08%
Last update: Oct 28, 4:00 PM

Latigo Biotherapeutics (LTGO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Sep 3, 2026 | $-27.59 | $-0.46 | -5897.8 % |
Quarterly Revenue (Billions)
| Metric | Q2 '26 |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Estimate | $-0.46 |
| Actual | $-27.59 |
| Surprise | -5897.8% |
| Revenue | |
| Estimate | — |
| Actual | $0 |
| Surprise | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.67 | $-0.85 |
| Revenue | ||
| Consensus | — | — |